Liver Disease Clinical Trials in Philadelphia

Showing 1-20 of 91 trials

Genetic Collection Protocol

NCT05272319

This study involves the one-time collection of whole blood or saliva samples for the extraction and storage of DNA for use in ongoing and future ChiLDReN studies.

Liver Diseases

Arbor Research Collaborative for Health213 participantsStarted Apr 2022

Los Angeles, California, United States • San Francisco, California, United States • Aurora, Colorado, United States +10 more locations

Active Not RecruitingPhase 3< 1 mile

A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

NCT06161571

The aim of this study is to assess the safety and tolerability of EFX compared to placebo in subjects with non-invasively diagnosed NASH/MASH and NAFLD/MASLD.

NASH/MASHNAFLD/MASLD

Akero Therapeutics, Inc700 participantsStarted Nov 2023

Birmingham, Alabama, United States • Chandler, Arizona, United States • Flagstaff, Arizona, United States +208 more locations

Genetic Collection Protocol

A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Liver Disease Trials in Other Cities

DILIN - Prospective Study

Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

An Observational Study of Patients With Chronic Liver Disease

A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

A Phase 3 Study to Evaluate the Effect of Resmetirom on Clinical Outcomes in Patients With Well-compensated NASH Cirrhosis (MAESTRO-NASH-OUTCOMES)

GATT-Patch Versus SURGICEL® Original in Minimally Invasive Liver and Gallbladder Surgery

Study of Seladelpar in Participants With Primary Biliary Cholangitis (PBC)

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV

Liver Cirrhosis Network Cohort Study

A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013)

Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis

Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI)

Communication During Hospitalization About Resuscitation Trial

A Phase IIb Study to Evaluate the Safety of Zibotentan/Dapagliflozin in Participants With Cirrhosis-ZEAL-UNLOCK

A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy

A Single-Ascending and Repeated Dose Study of LY3849891 in Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Other Conditions in Philadelphia